Duchenne Muscular Dystrophy Market
The market size of Duchenne Muscular Dystrophy in the 7 MM was found to be USD 266.06 Million in 2017. The United States accounts for the largest Duchenne Muscular Dystrophy (DMD) market size in comparison to EU5 and Japan. The total diagnosed DMD prevalent population in 2017 was 27,685 (in 7MM). The key players in Duchenne Muscular Dystrophy Markt include Sarepta Therapeutics, Santhera Pharmaceuticals, Italfarmaco, Catabasis Pharmaceuticals, NS Pharma, Pfizer, Taiho Pharmaceutical, FibroGen, Daiichi Sankyo, Hoffmann-La Roche, Nobelpharma, Cumberland Pharma, and many others. For more details visit: https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market#infographics #Duchenne Muscular Dystrophy #Duchenne Muscular Dystrophy Market #Duchenne Muscular Dystrophy Epidemiology #Duchenne Muscular Dystrophy key companies #Duchenne Muscular Dystrophy market size #DMD
46 views • 1 slides